Symposium - Measuring Progress Towards Viral Hepatitis Elimination Goals - Data for Action (Epidemiology, Public Health & Prevention Theme)
Tracks
.
| Monday, August 13, 2018 |
| 4:15 PM - 5:45 PM |
| Hall M (Ground Floor) |
Details
Learning Objectives - To understand the optimal set of indicators for measuring HBV and HCV elimination progress and the available sources of data in Australia that can be feasibly accessed to measure these indicators; -
To assist health services and local health areas to understand HBV and HCV indicators that might be able to be measured at the local level and how they can be tracking their own progress; -
To understand the challenges in measuring and in achieving elimination targets
Speaker
Professor Margaret Hellard
Deputy Director
Burnet Institute
Strategies, Targets and Indicators. How Will We Measure our Progress Towards Hepatitis B and Hepatitis C Elimination
4:15 PM - 4:30 PMBiography
Professor Margaret Hellard is the Deputy Director at the Burnet Institute and Head of Hepatitis Services, Department of Infectious Disease at The Alfred Hospital Melbourne. She Co-Chairs of the WHO Strategic and Technical Advisory Committee on HIV and Viral Hepatitis. Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses and sexually transmitted infections
Prof Gregory Dore
Program Head, VHCRP
The Kirby Institute, UNSW
HBV and HCV Elimination Targets: Which are feasible?
4:30 PM - 4:45 PMBiography
Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Australia, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years.
Professor Benjamin Cowie
Director
WHO CC for Viral Hepatitis
Prof Gregory Dore
Program Head, VHCRP
The Kirby Institute, UNSW
Panel Discussion
Facilitator: Mark Stoove Panel: Richard Gray, Margaret Hellard, Greg Dore, Benjamin Cowie, Maryam Alavi, Timothy Duck, Phillip Read
5:15 PM - 5:45 PMBrief Overview
• What is the role of local responses to elimination or micro-elimination in overcoming the challenges and maintaining the momentum?
• What data is available to evaluate progress by priority populations/settings
• What indicators can be developed to ensure we can clearly identify whether any of these priority populations are being left behind/at risk of being left behind as we track towards viral hepatitis elimination?
• What data is available to evaluate progress by priority populations/settings
• What indicators can be developed to ensure we can clearly identify whether any of these priority populations are being left behind/at risk of being left behind as we track towards viral hepatitis elimination?
Biography
Chair
Richard Gray
Associate Professor
Kirby Institute
Mark Stoove
Head, Public Health Discipline, Co-Head of the HIV Elimination Program
Burnet Institute
